Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 560

1.

Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.

Tretter T, Schuler M, Schneller F, Brass U, Esswein M, Aman MJ, Huber C, Peschel C.

Cell Immunol. 1998 Oct 10;189(1):41-50.

PMID:
9758693
2.

Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.

Schuler M, Tretter T, Schneller F, Huber C, Peschel C.

Immunobiology. 1999 Feb;200(1):128-39.

PMID:
10084701
3.

Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.

Fluckiger AC, Rossi JF, Bussel A, Bryon P, Banchereau J, Defrance T.

Blood. 1992 Dec 15;80(12):3173-81.

4.

IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.

Fluckiger AC, Brière F, Zurawski G, Bridon JM, Banchereau J.

Immunology. 1994 Nov;83(3):397-403.

5.

Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.

Decker T, Schneller F, Sparwasser T, Tretter T, Lipford GB, Wagner H, Peschel C.

Blood. 2000 Feb 1;95(3):999-1006.

7.

Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.

Johnson-Léger C, Christenson JR, Holman M, Klaus GG.

J Immunol. 1998 Nov 1;161(9):4618-26.

8.

Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity.

Schattner EJ, Mascarenhas J, Reyfman I, Koshy M, Woo C, Friedman SM, Crow MK.

Blood. 1998 Apr 15;91(8):2689-97.

9.

Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.

Ranheim EA, Cantwell MJ, Kipps TJ.

Blood. 1995 Jun 15;85(12):3556-65.

10.
11.

Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.

Klaus SJ, Pinchuk LM, Ochs HD, Law CL, Fanslow WC, Armitage RJ, Clark EA.

J Immunol. 1994 Jun 15;152(12):5643-52.

PMID:
7515910
12.
13.

Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia.

Decker T, Flohr T, Trautmann P, Aman MJ, Holter W, Majdic O, Huber C, Peschel C.

Blood. 1995 Aug 1;86(3):1115-23.

14.
15.

Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.

Ghia P, Strola G, Granziero L, Geuna M, Guida G, Sallusto F, Ruffing N, Montagna L, Piccoli P, Chilosi M, Caligaris-Cappio F.

Eur J Immunol. 2002 May;32(5):1403-13.

16.

Inhibition of T cell/B cell interaction by B-CLL cells.

Kneitz C, Goller M, Wilhelm M, Mehringer C, Wohlleben G, Schimpl A, Tony HP.

Leukemia. 1999 Jan;13(1):98-104.

PMID:
10049067
17.

Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.

Wallgren A, Festin R, Gidlöf C, Dohlsten M, Kalland T, Tötterman TH.

Blood. 1993 Aug 15;82(4):1230-8.

18.

CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukaemia cells.

Söderberg O, Christiansen I, Carlsson M, Nilsson K.

Scand J Immunol. 1997 Jun;45(6):706-14.

19.

CD72 ligation regulates defective naive newborn B cell responses.

Howard LM, Reen DJ.

Cell Immunol. 1997 Feb 1;175(2):179-88.

PMID:
9023424
20.

CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells.

Nagumo H, Agematsu K, Shinozaki K, Hokibara S, Ito S, Takamoto M, Nikaido T, Yasui K, Uehara Y, Yachie A, Komiyama A.

J Immunol. 1998 Dec 15;161(12):6496-502.

Supplemental Content

Support Center